Daniel Faden MD
Head & Neck Microvascular Surgery, Head & Neck Oncologic Surgery, Rhinology & Paranasal Sinus Disease
Surgeon, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, Harvard Medical School
Join to View Full Profile
243 Charles StBoston, MA 02114
Dr. Faden is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- I am a board certified Head and Neck Surgeon and Translational Head and Neck Cancer Researcher. I completed my residency training at UCSF in Otolaryngology-Head and Neck Surgery, research fellowships at the NIH (genomics) and University of Pittsburgh (immunology) and clinical fellowships at UPMC in Head and Neck Oncologic Surgery and Cranial Base Surgery.
Education & Training
UPMC Medical EducationFellowship, Rhinology and Skull Base Surgery, 2017 - 2018- UPMC Medical EducationPost-Doctoral Fellowship, Allergy and Immunology, 2016 - 2018
- UPMC Medical EducationFellowship, Head & Neck Surgical Oncology/Microvascular Reconstruction, 2016 - 2017
University of California (San Francisco)Residency, Otolaryngology - Head and Neck Surgery, 2011 - 2016
Howard Hughes Medical InstituteFellowship, Genomics, 2010 - 2011
Boston University School of MedicineClass of 2011- The University of MichiganBS, 2002 - 2006
Certifications & Licensure
CA State Medical License 2013 - Present
MA State Medical License 2018 - 2027
PA State Medical License 2016 - 2018
American Board of Otolaryngology - Head and Neck Surgery Otolaryngology
Publications & Presentations
PubMed
- Spatial characterization of tertiary lymphoid structures as predictive biomarkers for immune checkpoint blockade in head and neck squamous cell carcinoma.Daniel A Ruiz-Torres, Michael E Bryan, Shun Hirayama, Ross D Merkin, Evelyn Luciani
Oncoimmunology. 2025-12-01 - Circulating tumor human papillomavirus DNA whole genome sequencing enables human papillomavirus-associated oropharynx cancer early detection.Dipon Das, Shun Hirayama, Ling Aye, Michael E Bryan, Saskia Naegele
Journal of the National Cancer Institute. 2025-09-10 - Financial instability, insurance, and transportation influence timely head and neck cancer care in the United States: Patient and healthcare worker perspectives.Sana Batool, Elisabeth E Hansen, Rosh K V Sethi, Eleni M Rettig, Laura A Goguen
Oral Oncology. 2025-09-03
Press Mentions
First-Ever Detection for Early Head and Neck Cancers Under DevelopmentSeptember 12th, 2025- Blood Test Identifies HPV-Associated Head and Neck Cancers up to 10 Years Before SymptomsSeptember 11th, 2025
- Scientists Can Now Spot Head and Neck Cancer 10 Years Before Symptoms Appear—Here’s HowSeptember 10th, 2025
- Join now to see all
Grant Support
- Dissecting temporal and spatial dynamics of immunotherapy resistanceMASSACHUSETTS EYE AND EAR INFIRMARY2021–2026
- Circulating HPV DNA as a Prediagnostic Marker of Oropharyngeal CancerUNIVERSITY OF KENTUCKY2022–2025
External Links
- Faden Labhttps://faden-lab.mgh.harvard.edu/faden-lab.html
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
